Awarded contract

Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

Details

Buyer: The Royal Marsden NHS Foundation Trusts
Supplier(s): Advanced Accelerator Application
Value: GBP 4,500,000
Topic: Pharmaceutical products
Published: 22 January 2021
Source: uk:find_a_tender

Tender description

Purchase of 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours Lot 1: The Royal Marsden Hospital NHS Foundation Trust needs to purchase 177Lu- Dotatate (Lutathera ®) to treat patients with neuroendocrine tumours

Timeline

Completed: Award published22 January 2021
Current notice
Completed: Award date22 January 2021

About the buyer

The Royal Marsden NHS Foundation Trusts is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Commercial Director	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Procurement Manager	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Category Lead	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Senior Buyer	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov
Contracts Manager	+44 •••• ••••••	••••••••@the-royal-marsden-nhs-foundation-trusts.gov